Skip to main content
OpenTrials
Completed

NCT Number: NCT07235579

Understanding Cauda Equina Syndrome

Cauda equina syndrome is a potentially devastating condition caused by compression of the cauda equina nerve roots. This can result in bowel, bladder and sexual dysfunction plus lower limb weakness, numbness, and pain. Cauda equina syndrome occurs infrequently but has serious potential morbidity and medico-legal consequences. This study aims to identify and describe the presentation and management of patients with cauda equina syndrome in the United Kingdom using trainee research collaborative networks. This will provide accurate incidence figures, establish current clinical practice, allow assessment of the adherence to national published standards of care, and determine patient outcomes from this condition. Accurate, up to date information about the presentation, management, and outcome of patients with cauda equina syndrome will inform standards of service design and delivery for this important but infrequent condition and help to identify future research priorities.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–120 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Neurosciences, Western General Hospital

Edinburgh, EH4 2XU, United Kingdom

About this study

Understanding Cauda Equina Syndrome (UCES) is a prospective cohort study of patients with confirmed CES managed at specialist spinal centres in the UK.

Cases will be identified by neurosurgical or orthopaedic trainees in each specialist centre through daily screening of tertiary referrals and admissions to specialist spinal services. All patients managed as CES by the treating team will be included in this audit. CES will be divided into CES suspected (CESS), CES incomplete (CESI), and CES retention (CESR).

Data regarding timing and type of symptom onset, referral, investigation, management, and outcome will be recorded anonymously on a secure database by the local trainee investigator during the patient's hospital admission and after discharge. Patient consent will be sought for the use of their data and patients will be asked to complete patient reported outcome measures representing their condition before surgery and up to one year after surgery. This data will be compared with care quality statements and published outcome data for CES.

The study will recruit for one year. Cases will be identified from admissions to spinal units between 1st June 2018 until 31st May 2019. The last one year follow up assessments will be sent to participants on 1st June 2020.

This is an observational study. No changes to routine patient care will occur during this study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • For inclusion in this study, the patient must:
  • be over 18 years old;
  • be admitted to a specialist spinal service in the UK between 1st June 2018 and 31st May 2019;
  • have capacity to provide informed consent for participation in this study; and
  • have a diagnosis of clinical CES and structural compression of the cauda equina on imaging as determined by the treating clinician.
  • Clinical CES includes any disturbance of saddle sensation, bladder function, bowel function, sexual dysfunction and bilateral sciatica associated with radiological compression of the cauda equina. The cauda equina compression can be due to any cause, including, but not limited to, disc, tumour, infection, etc.

Exclusion criteria

  • • Patients under 18 years old
  • Patients undergoing emergent decompression for unilateral motor or sensory symptoms (eg foot drop), without clinical evidence of CES
  • Patients referred with suspected CES where the diagnosis is not confirmed, for example:

o Patients with the clinical symptoms and signs of CES without radiological evidence of cauda equina compression

  • Patients not admitted to participating spinal centres in the UK
  • Patients admitted to a participating spinal centre before 1st June 2018 or after 31st May 2019
  • Patients who are unable to provide informed consent for participation in this study

Treatment and study plan

Primary outcomes

  1. Identify the number of cases of Cauda Equina Syndrome (CES) in the UK in all collaborating centres

    Time frame: June 2018-June 2021

    Cases will be identified by neurosurgical or orthopaedic trainees in each specialist centre through daily screening of tertiary referrals and admissions to specialist spinal services. All patients managed as CES by the treating team will be counted.

Secondary outcomes

  1. Describe the presenting symptoms and signs in patients with CES

    Time frame: June 2018-June 2021

    Study participants who have consented to participate will also be asked to fill out details about their patient journey to the spinal unit, their symptoms, patient reported outcome measures, and service usage. These will be collected electronically anonymously via the electronic database and linked to the patient record.

  2. Describe the pathways of presentation to specialist spinal services for patients with CES in the UK and Ireland

    Time frame: June 2018-June 2021

    Patients will be asked about their care pathway prior to and after entering hospital

  3. Describe the type and timing of investigation of patients with CES

    Time frame: June 2018-June 2021

    Timing of MRI scans will be gathered by a member of the local clinical care team. Time will be divided into hours from symptom onset (patient and clinician rated).

  4. Describe the medical and surgical management of CES

    Time frame: June 2018- June 2021

    Type and timing of medical or surgical management of patients with cauda equina syndrome will be gathered by a member of the local clinical care team. Time will be divided into hours from symptom onset (patient and clinician rated), type will be a drop down menu of various types of operation and 'other' with room for explanation.

  5. Describe clinical outcomes for patients with CES using validated patient reported outcome measures, stratified by presentation, investigations, and management

    Time frame: June 2018-June 2021

    Patient reported outcome measures will be used such as the ODI.

Sponsors and collaborators

Lead sponsor

University of Edinburgh

Other

Collaborators

  • Barking, Havering and Redbridge University Hospitals NHS Trust
  • Barts & The London NHS Trust
  • Brighton and Sussex University Hospitals NHS Trust
  • Buckinghamshire Healthcare NHS Trust
  • Cambridge University Hospitals NHS Foundation Trust
  • City Hospitals Sunderland NHS Foundation Trust
  • East Kent Hospitals University NHS Foundation Trust
  • Hull University Teaching Hospitals NHS Trust
  • Imperial College Healthcare NHS Trust
  • King's College Hospital NHS Trust
  • Lancashire Teaching Hospitals NHS Foundation Trust
  • Milton Keynes University Hospital NHS Foundation Trust
  • NHS Lothian
  • Newcastle-upon-Tyne Hospitals NHS Trust
  • Norfolk and Norwich University Hospitals NHS Foundation Trust
  • North Bristol NHS Trust
  • Northern Care Alliance NHS Foundation Trust
  • Nottingham University Hospitals NHS Trust
  • Oxford University Hospitals NHS Trust
  • Royal Brompton & Harefield NHS Foundation Trust
  • Royal Cornwall Hospitals Trust
  • Royal Devon and Exeter NHS Foundation Trust
  • Sheffield Teaching Hospitals NHS Foundation Trust
  • Somerset NHS Foundation Trust
  • South Tees Hospitals NHS Foundation Trust
  • St George's University Hospitals NHS Foundation Trust
  • The Ipswich Hospital NHS Trust
  • The Leeds Teaching Hospitals NHS Trust
  • University College London Hospitals
  • University Hospital Birmingham NHS Foundation Trust
  • University Hospital Plymouth NHS Trust
  • University Hospital Southampton NHS Foundation Trust
  • University Hospitals Coventry and Warwickshire NHS Trust
  • University Hospitals of Derby and Burton NHS Foundation Trust
  • Walton Centre NHS Foundation Trust

Registry information

Official study title

Understanding Cauda Equina Syndrome:

Acronym: UCES

Important dates

Study start
2018
Primary completion
2022
Study completion
2022
First posted
Nov 19, 2025
Registry last updated
Nov 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.